# AJOVY

NDC: 51759-202
Generic name: fremanezumab-vfrm
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20200329

FDA application: BLA761089

## Active ingredients

- FREMANEZUMAB: 225 mg/1.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51759-202"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51759-202
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=98e344ea-5916-4947-b6f2-4a76ccc04b6b